These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10308894)

  • 1. The cost benefit debate in evaluating health education.
    Parrish R
    Health Soc Serv J; 1979 Apr; 89(4638):442-4. PubMed ID: 10308894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to evaluate health promotion.
    Green LW
    Hospitals; 1979 Oct; 53(19):106-8. PubMed ID: 112025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cost effectiveness analysis in health care evaluation.
    Atherly A; Culler SD; Becker ER
    Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A health care evaluation framework.
    Champagne F; Contandriopoulos AP; Pineault R
    Health Manage Forum; 1986; 7(2):57-65. PubMed ID: 10311580
    [No Abstract]   [Full Text] [Related]  

  • 6. An economic evaluation of three physiotherapy treatments for non-specific neck disorders alongside a randomized trial.
    Lewis M; James M; Stokes E; Hill J; Sim J; Hay E; Dziedzic K
    Rheumatology (Oxford); 2007 Nov; 46(11):1701-8. PubMed ID: 17956916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.
    Negrín MA; Vázquez-Polo FJ
    J Health Econ; 2008 Sep; 27(5):1250-9. PubMed ID: 18490067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of medical action and of action in public health. A clarification of concepts with special reference to quality of care.
    Grémy F
    Eff Health Care; 1983 Jun; 1(1):11-23. PubMed ID: 10310173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
    Giraldes Mdo R
    Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The economies of health education--basic comments on health education].
    Oberender P
    Offentl Gesundheitswes; 1987 Oct; 49(10):517-21. PubMed ID: 2960928
    [No Abstract]   [Full Text] [Related]  

  • 14. Incremental cost effectiveness evaluation in clinical research.
    Krummenauer F; Landwehr I
    Eur J Med Res; 2005 Jan; 10(1):18-22. PubMed ID: 15737949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three year study on the assessment of EPSDT practices and cost.
    J Medicaid Manage; 1977; 1(4):55-8. PubMed ID: 10308915
    [No Abstract]   [Full Text] [Related]  

  • 17. A new methodology for cost-effectiveness studies of domestic radon remediation programmes: quality-adjusted life-years gained within primary care trusts in central England.
    Coskeran T; Denman A; Phillips P; Gillmore G; Tornberg R
    Sci Total Environ; 2006 Jul; 366(1):32-46. PubMed ID: 16574198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and Life After Survival of a Cardiac Arrest (ALASCA) and the effectiveness of an early intervention service: design of a randomised controlled trial.
    Moulaert VR; Verbunt JA; van Heugten CM; Bakx WG; Gorgels AP; Bekkers SC; de Krom MC; Wade DT
    BMC Cardiovasc Disord; 2007 Aug; 7():26. PubMed ID: 17723148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and outcome implications of the organisation of vascular services.
    Michaels J; Brazier J; Palfreyman S; Shackley P; Slack R
    Health Technol Assess; 2000; 4(11):i-iv, 1-191. PubMed ID: 10944744
    [No Abstract]   [Full Text] [Related]  

  • 20. Measuring the "payoff" of worksite health strategies.
    Stason WB
    Bus Health; 1984 Mar; 1(4):19-22. PubMed ID: 10310429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.